Back
Theravance Biopharma, Inc. Stock Price Chart
This AI Layer Just Raised Its Share Price
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
44
TBPH
Theravance Biopharma, Inc.
Last Price:
$18.71
Seasonality Move:
7.18%
7 Day Trial
ALL ACCESS PASS
$
7
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
The current trend is moderately bullish and TBPH is experiencing selling pressure, which indicates risk of future bearish movement.
Theravance Biopharma, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.17 | Sell |
| 20-day SMA: | 18.01 | Buy |
| 50-day SMA: | 15.78 | Buy |
| 200-day SMA: | 12.02 | Buy |
| 8-day EMA: | 18.88 | Sell |
| 20-day EMA: | 18 | Buy |
| 50-day EMA: | 16.32 | Buy |
| 200-day EMA: | 12.96 | Buy |
Theravance Biopharma, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.05 | Buy |
| Relative Strength Index (14 RSI): | 59.08 | Buy |
| Chaikin Money Flow: | -191095 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.51 - 19.23) | Buy |
| Bollinger Bands (100): | (12 - 16.56) | Buy |
Theravance Biopharma, Inc. Technical Analysis
| Nov 20 | Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 20 | 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Theravance Biopharma, Inc. Stock
Is Theravance Biopharma, Inc. Stock a Buy?
-
Theravance Biopharma, Inc. share price is 18.70 while TBPH 8-day simple moving average is 19.17, which is a Sell signal.
-
The stock price of TBPH is 18.70 while Theravance Biopharma, Inc. 20-day SMA is 18.01, which makes it a Buy.
-
Theravance Biopharma, Inc. 50-day simple moving average is 15.78 while TBPH share price is 18.70, making it a Buy technically.
-
TBPH stock price is 18.70 and Theravance Biopharma, Inc. 200-day simple moving average is 12.02, creating a Buy signal.
TBPH Technical Analysis vs Fundamental Analysis
Sell
44
Theravance Biopharma, Inc. (TBPH)
is a Sell
Is Theravance Biopharma, Inc. a Buy or a Sell?
-
Theravance Biopharma, Inc. stock is rated a SellThe current Theravance Biopharma, Inc. [TBPH] share price is $18.70. The Score for TBPH is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
Theravance Biopharma, Inc. Stock Info
Market Cap:
947.6M
Price in USD:
18.70
Share Volume:
331.2K
Theravance Biopharma, Inc. 52-Week Range
52-Week High:
20.33
52-Week Low:
7.90
Sell
44
Theravance Biopharma, Inc. (TBPH)
is a Sell
Theravance Biopharma, Inc. Share Price Forecast
-
What is the Theravance Biopharma, Inc. stock price today?The Theravance Biopharma, Inc. stock price is 18.70 USD today.
-
Will TBPH stock go up or go down?Theravance Biopharma, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Theravance Biopharma, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Theravance Biopharma, Inc. is overvalued.
Is Theravance Biopharma, Inc. Stock a Buy?
-
Theravance Biopharma, Inc. share price is 18.70 while TBPH 8-day exponential moving average is 18.88, which is a Sell signal.
-
The stock price of TBPH is 18.70 while Theravance Biopharma, Inc. 20-day EMA is 18.00, which makes it a Buy.
-
Theravance Biopharma, Inc. 50-day exponential moving average is 16.32 while TBPH share price is 18.70, making it a Buy technically.
-
TBPH stock price is 18.70 and Theravance Biopharma, Inc. 200-day simple moving average is 12.96, creating a Buy signal.
Fundamental Analysis of Theravance Biopharma, Inc.
Is Theravance Biopharma, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.31 per share, and a decrease next year of $0.18 per share.
Technical Analysis of Theravance Biopharma, Inc.
Should I short Theravance Biopharma, Inc. stock?
-
TBPH Moving Average Covergence Divergence (MACD) indicator is 1.05, suggesting Theravance Biopharma, Inc. is a Buy
-
Theravance Biopharma, Inc. Relative Strength Index (RSI) is 59.08, which suggest Theravance Biopharma, Inc. is overbought
-
The Bollinger Bands (25) for Theravance Biopharma, Inc. is (15.51 - 19.23), which suggest Theravance Biopharma, Inc. is a Buy
-
The Bollinger Bands (100) for Theravance Biopharma, Inc. is (12 - 16.56), which suggest Theravance Biopharma, Inc. is a Buy
* Theravance Biopharma, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.